<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using EDGARfilings PROfile 8.0.0.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div style="text-align: center; color: rgb(255, 0, 0); font-weight: bold;">As filed with the Securities and Exchange Commission on January 14, 2022</div>
  <div style="text-align: right; color: rgb(0, 0, 0); font-weight: bold;">Registration No.&#160;333-</div>
  <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;">
  <div style="text-align: center; color: rgb(0, 0, 0); font-size: 14pt; font-weight: bold;">UNITED STATES SECURITIES AND EXCHANGE COMMISSION</div>
  <div style="text-align: center; color: rgb(0, 0, 0); font-size: 12pt; font-weight: bold;">WASHINGTON, D.C. 20549</div>
  <div>&#160;</div>
  <div style="text-align: center; color: rgb(0, 0, 0); font-size: 18pt; font-weight: bold;">FORM S-8</div>
  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">REGISTRATION STATEMENT</div>
  <div style="text-align: center; color: rgb(0, 0, 0); font-style: italic; font-weight: bold;">UNDER THE SECURITIES ACT OF 1933</div>
  <div>&#160;</div>
  <div style="text-align: center; color: rgb(0, 0, 0); font-size: 24pt; font-weight: bold;">CHEMBIO DIAGNOSTICS, INC.</div>
  <div style="text-align: center; color: rgb(0, 0, 0); font-style: italic;">(Exact name of registrant as specified in its charter)</div>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" id="z219812a4f83b42ef94b7e20a31fd5936" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

      <tr>
        <td style="width: 49.01%; vertical-align: top;">
          <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Nevada</div>
        </td>
        <td style="width: 2%; vertical-align: top;">&#160;</td>
        <td style="width: 49%; vertical-align: top;">
          <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">88-0425691</div>
        </td>
      </tr>
      <tr>
        <td style="width: 49.01%; vertical-align: top;">
          <div style="text-align: center; color: rgb(0, 0, 0); font-style: italic;">(State or other jurisdiction of</div>
        </td>
        <td style="width: 2%; vertical-align: top;">&#160;</td>
        <td style="width: 49%; vertical-align: top;">
          <div style="text-align: center; color: rgb(0, 0, 0); font-style: italic;">(I.R.S. Employer Identification No.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 49.01%; vertical-align: top;">
          <div style="text-align: center; color: rgb(0, 0, 0); font-style: italic;">Incorporation or organization)</div>
        </td>
        <td style="width: 2%; vertical-align: top;">&#160;</td>
        <td style="width: 49%; vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 49.01%; vertical-align: top;" rowspan="1">&#160;</td>
        <td style="width: 2%; vertical-align: top;" rowspan="1">&#160;</td>
        <td style="width: 49%; vertical-align: top;" rowspan="1">&#160;</td>
      </tr>
      <tr>
        <td style="width: 49.01%; vertical-align: top;">
          <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">555 Wireless Blvd.</div>
        </td>
        <td style="width: 2%; vertical-align: top;">&#160;</td>
        <td style="width: 49%; vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 49.01%; vertical-align: top;">
          <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Hauppauge, New York</div>
        </td>
        <td style="width: 2%; vertical-align: top;">&#160;</td>
        <td style="width: 49%; vertical-align: top;">
          <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">11788</div>
        </td>
      </tr>
      <tr>
        <td style="width: 49.01%; vertical-align: top;">
          <div style="text-align: center; color: rgb(0, 0, 0); font-style: italic;">(Address of principal executive offices)</div>
        </td>
        <td style="width: 2%; vertical-align: top;">&#160;</td>
        <td style="width: 49%; vertical-align: top;">
          <div style="text-align: center; color: rgb(0, 0, 0); font-style: italic;">(Zip code)</div>
        </td>
      </tr>

  </table>
  <div><br>
  </div>
  <div>
    <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 10%; color: #000000; text-align: center;"></div>
  <br>
  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Employment Agreement dated as of December 30, 2021 with Lawrence J. Steenvoorden</div>
  <div style="text-align: center; color: rgb(0, 0, 0); font-style: italic;">(Full title of the plan)</div>
  <div>&#160;
    <hr noshade="noshade" align="center" style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 10%; color: #000000; text-align: center;"></div>
  <div> <br>
  </div>
  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Richard L. Eberly</div>
  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Chief Executive Officer and President</div>
  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Chembio Diagnostics, Inc.</div>
  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">555 Wireless Blvd., Hauppauge, New York 11788</div>
  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(631) 924-1135</div>
  <div style="text-align: center; color: rgb(0, 0, 0); font-style: italic;">(Name, address, including zip code, and telephone number, including area code, of agent for service)</div>
  <div>&#160;</div>
  <div style="text-align: center; color: rgb(0, 0, 0); font-style: italic;">With a copy to:</div>
  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Mark L. Johnson</div>
  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Bella Zaslavsky</div>
  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">K&amp;L Gates LLP</div>
  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">One Lincoln Street, Boston, Massachusetts 02111</div>
  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">(617) 261-3260</div>
  <div>&#160;</div>
  <div style="text-align: justify; color: rgb(0, 0, 0);">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the
    definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</div>
  <div> <br>
  </div>
  <table cellspacing="0" cellpadding="0" border="0" id="zc081a4c6c0044b638251c18705aa0954" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

      <tr>
        <td style="width: 25%; vertical-align: top;">
          <div style="color: rgb(0, 0, 0);">Large accelerated filer</div>
        </td>
        <td style="width: 39.42%; vertical-align: top;">
          <div style="color: rgb(0, 0, 0);">&#9744;</div>
        </td>
        <td style="width: 31.42%; vertical-align: top;">
          <div style="color: rgb(0, 0, 0);">Accelerated filer</div>
        </td>
        <td style="width: 5.12%; vertical-align: top;">
          <div style="text-align: right; color: rgb(0, 0, 0);">&#9744;</div>
        </td>
      </tr>
      <tr>
        <td style="width: 25%; vertical-align: top;">
          <div style="color: rgb(0, 0, 0);">Non-accelerated filer</div>
        </td>
        <td style="width: 39.42%; vertical-align: top;">
          <div style="color: rgb(0, 0, 0);">&#9744;</div>
        </td>
        <td style="width: 31.42%; vertical-align: top;">
          <div style="color: rgb(0, 0, 0);">Smaller reporting company</div>
        </td>
        <td style="width: 5.12%; vertical-align: top;">
          <div style="text-align: right; color: rgb(0, 0, 0);">&#9746;</div>
        </td>
      </tr>
      <tr>
        <td style="vertical-align: top;" colspan="2">&#160;</td>
        <td style="width: 31.42%; vertical-align: top;">
          <div style="color: rgb(0, 0, 0);">Emerging growth company</div>
        </td>
        <td style="width: 5.12%; vertical-align: top;">
          <div style="text-align: right; color: rgb(0, 0, 0);">&#9744;</div>
        </td>
      </tr>

  </table>
  <div> <br>
  </div>
  <div style="text-align: justify; color: rgb(0, 0, 0);">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revise financial accounting standards
    provided pursuant to Section 7(a)(2)(B) of the Securities Act. &#9744;</div>
  <div>&#160;</div>
  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">CALCULATION OF REGISTRATION FEE</div>
  <table cellspacing="0" cellpadding="0" border="0" id="z90fa1f7f5c9245c8a1e7332177d87a83" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

      <tr>
        <td style="width: 41.11%; vertical-align: bottom; border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Title of Securities to be Registered</div>
        </td>
        <td nowrap="nowrap" style="width: 11.96%; vertical-align: bottom; border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Amount to be</div>
          <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">registered(1)</div>
        </td>
        <td nowrap="nowrap" style="width: 18.04%; vertical-align: bottom; border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Proposed maximum</div>
          <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">offering price per</div>
          <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">share(2)</div>
        </td>
        <td nowrap="nowrap" style="width: 18.04%; vertical-align: bottom; border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Proposed maximum</div>
          <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">aggregate offering</div>
          <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">price(2)</div>
        </td>
        <td nowrap="nowrap" style="width: 10.84%; vertical-align: bottom; border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Amount of</div>
          <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">registration</div>
          <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">fee</div>
        </td>
      </tr>
      <tr>
        <td style="width: 41.11%; vertical-align: middle; border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
          <div style="color: rgb(0, 0, 0);">Common stock, $0.01 par value per share</div>
        </td>
        <td style="width: 11.96%; vertical-align: middle; border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
          <div style="text-align: center; color: rgb(0, 0, 0);">460,714</div>
        </td>
        <td style="width: 18.04%; vertical-align: middle; border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
          <div style="text-align: center; color: rgb(0, 0, 0);">$1.11</div>
        </td>
        <td style="width: 18.04%; vertical-align: middle; border-right: 2px solid rgb(0, 0, 0); border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
          <div style="text-align: center; color: rgb(0, 0, 0);">$511,392.54</div>
        </td>
        <td style="width: 10.84%; vertical-align: middle; border-top: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); background-color: rgb(204, 238, 255);">
          <div style="text-align: center; color: rgb(0, 0, 0);">$47.41</div>
        </td>
      </tr>

  </table>
  <table cellspacing="0" cellpadding="0" id="zf54e55cc2581430b9ddc63335c84b376" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

      <tr>
        <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(1)</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div style="color: rgb(0, 0, 0);">Consists of shares authorized for issuance under the registrant&#8217;s Employment Agreement dated as of December 30, 2021 with Lawrence J. Steenvoorden. In accordance with Rule 416 under the Securities Act of 1933,
            this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions.</div>
        </td>
      </tr>

  </table>
  <table cellspacing="0" cellpadding="0" id="z05721d41d5e64c0a9f89f6603d3aa9ef" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

      <tr>
        <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(2)</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div style="color: rgb(0, 0, 0);">Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and (h) under the Securities Act of 1933 and based upon the average of the high and low prices of the registrant&#8217;s
            common stock as reported on the Nasdaq Capital Market on January 7, 2022.</div>
        </td>
      </tr>

  </table>
  <div> <br>
  </div>
  <div>
    <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"> </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageBreak" style="page-break-after:always;">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: justify; color: rgb(0, 0, 0);">This Registration Statement on Form S-8 is being filed by Chembio Diagnostics, Inc. (the &#8220;Company&#8221;) for the purpose of registering 460,714 shares of the Company&#8217;s common stock, $0.01 par value per
    share (&#8220;Common Stock&#8221;), authorized for issuance under the Employment Agreement dated as of December 30, 2021 between the Company and Lawrence J. Steenvoorden. Such Employment Agreement is referred to below as the &#8220;Plan.&#8221;</div>
  <div>&#160;</div>
  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">PART I</div>
  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS</div>
  <div>&#160;</div>
  <div>
    <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="z8bdaa1af81304b58b5f854b835125109" class="DSPFListTable">

        <tr style="vertical-align: top;">
          <td style="vertical-align: top; width: 45pt;">
            <div style="text-align: left;"><font style="font-weight: bold; color: rgb(0, 0, 0);">Item 1.</font></div>
          </td>
          <td style="align: left; vertical-align: top; width: auto;">
            <div style="text-align: left;"><font style="font-weight: bold; color: rgb(0, 0, 0);">Plan Information.</font></div>
          </td>
        </tr>

    </table>
  </div>
  <div>&#160;</div>
  <div style="text-align: justify; color: rgb(0, 0, 0);">The information required by Item 1 is included in documents sent or given by the Company to the participant in the Plan pursuant to Rule 428(b)(1) of the Securities Act of 1933 (the &#8220;Securities
    Act&#8221;).</div>
  <div>&#160;</div>
  <div>
    <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="z56a64ed5031043149cdeafa0b609b449" class="DSPFListTable">

        <tr style="vertical-align: top;">
          <td style="vertical-align: top; width: 45pt;">
            <div style="text-align: left;"><font style="font-weight: bold; color: rgb(0, 0, 0);">Item 2.</font></div>
          </td>
          <td style="align: left; vertical-align: top; width: auto;">
            <div style="text-align: left;"><font style="font-weight: bold; color: rgb(0, 0, 0);">Registrant Information and Employee Plan Annual Information.</font></div>
          </td>
        </tr>

    </table>
  </div>
  <div>&#160;</div>
  <div style="text-align: justify; color: rgb(0, 0, 0);">The written statement required by Item 2 is included in documents sent or given by the Company to participant in the Plan pursuant to Rule 428(b)(1) of the Securities Act.</div>
  <div>&#160;</div>
  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">PART II</div>
  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</div>
  <div>&#160;</div>
  <div>
    <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="z86ccf66a0b434d7e9fcf65bd08b8d737" class="DSPFListTable">

        <tr style="vertical-align: top;">
          <td style="vertical-align: top; width: 45pt;">
            <div style="text-align: left;"><font style="font-weight: bold; color: rgb(0, 0, 0);">Item 3.</font></div>
          </td>
          <td style="align: left; vertical-align: top; width: auto;">
            <div style="text-align: left;"><font style="font-weight: bold; color: rgb(0, 0, 0);">Incorporation of Documents by Reference.</font></div>
          </td>
        </tr>

    </table>
  </div>
  <div>&#160;</div>
  <div style="text-align: justify; color: rgb(0, 0, 0);">The following documents filed by the Company with the Securities and Exchange Commission are incorporated by reference in this registration statement:</div>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" id="zd5128ff9963040b493a280ab00d3a5db" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

      <tr>
        <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(a)</td>
        <td style="width: auto; vertical-align: top;">
          <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);">the Company&#8217;s latest annual report on </font><a href="https://www.sec.gov/Archives/edgar/data/0001092662/000114036121008210/brhc10021388_10k.htm">Form 10-K</a><font style="color: rgb(0, 0, 0);"> filed pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) that contains audited financial statements for the Company&#8217;s latest fiscal year for which such statements have
              been filed;</font></div>
        </td>
      </tr>

  </table>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" id="z6fd746560f92493799865b211e844bd4" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

      <tr>
        <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(b)</td>
        <td style="width: auto; vertical-align: top;">
          <div style="color: rgb(0, 0, 0); text-align: justify;">all other reports filed pursuant to Section 13(a) or 15(d) of the Exchange Act since the end of the fiscal year covered by the annual report referred to in (a) above; and</div>
        </td>
      </tr>

  </table>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" id="z4e2556fcd21043ddaa3bec8dd9899626" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

      <tr>
        <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(c)</td>
        <td style="width: auto; vertical-align: top;">
          <div style="text-align: justify;"><font style="color: rgb(0, 0, 0);">the description of the Common Stock set forth in </font><a href="https://www.sec.gov/Archives/edgar/data/0001092662/000114036121008210/brhc10021388_ex4-2.htm">Exhibit 4.2</a><font style="color: rgb(0, 0, 0);"> to the Company&#8217;s Annual Report on </font>Form 10-K<font style="color: rgb(0, 0, 0);"> for the fiscal year ended December 31, 2020, filed with the SEC on March 11, 2021, together with any amendment or report
              filed with the SEC for the purpose of updating such description.</font></div>
        </td>
      </tr>

  </table>
  <div>&#160;</div>
  <div style="text-align: justify; color: rgb(0, 0, 0);">All reports and other documents subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act prior to the filing of a post-effective amendment that indicates
    that all securities offered have been sold, or that deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this registration statement and to be part of this registration statement from the respective dates
    of the filing of such reports and other documents.</div>
  <div>&#160;</div>
  <div>
    <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="z332cb1fe966941a49f64aa3b61d4bbad" class="DSPFListTable">

        <tr style="vertical-align: top;">
          <td style="vertical-align: top; width: 45pt;">
            <div style="text-align: left;"><font style="font-weight: bold; color: rgb(0, 0, 0);">Item 4.</font></div>
          </td>
          <td style="align: left; vertical-align: top; width: auto;">
            <div style="text-align: left;"><font style="font-weight: bold; color: rgb(0, 0, 0);">Description of Securities.</font></div>
          </td>
        </tr>

    </table>
  </div>
  <div>&#160;</div>
  <div style="color: rgb(0, 0, 0);">Not applicable.</div>
  <div>&#160;</div>
  <div>
    <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="zb934444caff4494faae2b583977bb6ff" class="DSPFListTable">

        <tr style="vertical-align: top;">
          <td style="vertical-align: top; width: 45pt;">
            <div style="text-align: left;"><font style="font-weight: bold; color: rgb(0, 0, 0);">Item 5.</font></div>
          </td>
          <td style="align: left; vertical-align: top; width: auto;">
            <div style="text-align: left;"><font style="font-weight: bold; color: rgb(0, 0, 0);">Interests of Named Experts and Counsel</font></div>
          </td>
        </tr>

    </table>
  </div>
  <div>&#160;</div>
  <div style="text-align: justify; margin-right: 0.1pt; margin-left: 0.1pt; color: rgb(0, 0, 0);">Ballard Spahr LLP has opined as to the legality of the shares of Common Stock being offered by this registration statement.</div>
  <div>&#160;</div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageBreak" style="page-break-after:always;">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="z2a3987e5ff4146439bf8b9752e9e42bc" class="DSPFListTable">

        <tr style="vertical-align: top;">
          <td style="vertical-align: top; width: 45pt;">
            <div style="text-align: left;"><font style="font-weight: bold; color: rgb(0, 0, 0);">Item 6.</font></div>
          </td>
          <td style="align: left; vertical-align: top; width: auto;">
            <div style="text-align: left;"><font style="font-weight: bold; color: rgb(0, 0, 0);">Indemnification of Directors and Officers.</font></div>
          </td>
        </tr>

    </table>
  </div>
  <div>&#160;</div>
  <div style="text-align: justify; color: rgb(0, 0, 0);">The Company&#8217;s bylaws provide that it will indemnify any of its directors, officers, other employees or agents against expenses (including attorneys&#8217; fees), judgments, fines and amounts paid in
    settlement actually and reasonably incurred by such director, officer, other employee or agent in connection with any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, relating to
    service for or at the request of the Company. The Company will not indemnify a director, officer, other employee or agent if in relation to matters such director, officer, other employee or agent is adjudged in the action, suit or proceeding to not
    have acted in good faith and in a manner reasonably believed to be in or not opposed to the best interests of the Company in the performance of the individual&#8217;s duties.</div>
  <div>&#160;</div>
  <div style="text-align: justify; color: rgb(0, 0, 0);">The Company&#8217;s bylaws also provide that it will advance expenses (including attorneys&#8217; fees) incurred by an officer or director defending an action, suit or proceeding, upon receipt of an undertaking
    by or on behalf of such officer or director to repay such amount if that officer of director is determined to not be entitled to indemnification. Such expenses incurred by other employees and agents may be paid in advance by the Company upon certain
    terms and conditions deemed appropriate by the board of directors of the Company.</div>
  <div>&#160;</div>
  <div style="text-align: justify; color: rgb(0, 0, 0);">The Company&#8217;s articles of incorporation provide that no director will be personally liable to the Company or its stockholders for monetary damages for breach of fiduciary duty as a director, except
    that the director&#8217;s liability will not be eliminated or limited: (A) for acts or omissions involving intentional misconduct, fraud or a knowing violation of the law; or (B) for the payment of any distribution in violation of Nevada law.</div>
  <div>&#160;</div>
  <div style="text-align: justify; color: rgb(0, 0, 0);">Nevada law permits a Nevada corporation, such as the Company, to indemnify its directors and officers in certain circumstances. Specifically, Section 78.7502 of the Nevada Revised Statutes provides
    as follows:</div>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" id="ze69d4c3c16044296bf6c1697f2bdcf32" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

      <tr>
        <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);">&#8220;(1)</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div style="color: rgb(0, 0, 0);">A corporation may indemnify pursuant to this subsection any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil,
            criminal, administrative or investigative, except an action by or in the right of the corporation, by reason of the fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of
            the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses, including attorneys&#8217; fees, judgments, fines and amounts paid in settlement actually and
            reasonably incurred by the person in connection with the action, suit or proceeding if the person: (a) is not liable pursuant to Nevada Revised Statutes 78.138; or (b) acted in good faith and in a manner which he or she reasonably believed to
            be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe the conduct was unlawful. The termination of any action, suit or proceeding by judgment,
            order, settlement, conviction or upon a plea of nolo contendere or its equivalent, does not, of itself, create a presumption that the person is liable pursuant to Nevada Revised Statutes 78.138 or did not act in good faith and in a manner which
            he or she reasonably believed to be in or not opposed to the best interests of the corporation, or that, with respect to any criminal action or proceeding, he or she had reasonable cause to believe that the conduct was unlawful.</div>
        </td>
      </tr>

  </table>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" id="z78031a1f97434a3bbd43c237ddcba46b" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

      <tr>
        <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);">&#8220;(2)</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div style="color: rgb(0, 0, 0);">A corporation may indemnify pursuant to this subsection any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the
            corporation to procure a judgment in its favor by reason of the fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or
            agent of another corporation, partnership, joint venture, trust or other enterprise against expenses, including amounts paid in settlement and attorneys&#8217; fees actually and reasonably incurred by the person in connection with the defense or
            settlement of the action or suit if the person: (a) is not liable pursuant to Nevada Revised Statutes 78.138; or (b) acted in good faith and in a manner which he or she reasonably believed to be in or not opposed to the best interests of the
            corporation. Indemnification pursuant to this section may not be made for any claim, issue or matter as to which such a person has been adjudged by a court of competent jurisdiction, after exhaustion of any appeals taken therefrom, to be liable
            to the corporation or for amounts paid in settlement to the corporation, unless and only to the extent that the court in which the action or suit was brought or other court of competent jurisdiction determines upon application that in view of
            all the circumstances of the case, the person is fairly and reasonably entitled to indemnity for such expenses as the court deems proper.</div>
        </td>
      </tr>

  </table>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" id="z21f664cd08544d389684e142f5c244f3" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

      <tr>
        <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0);">&#8220;(3)</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div style="color: rgb(0, 0, 0);">Any discretionary indemnification pursuant to this section, unless ordered by a court or advanced pursuant to subsection 2 of Nevada Revised Statutes 78.751, may be made by the corporation only as authorized in
            each specific case upon a determination that the indemnification of a director, officer, employee or agent of a corporation is proper under the circumstances. The determination must be made by: (a)&#8194;The stockholders; (b) The board of directors,
            by majority vote of a quorum consisting of directors who were not parties to the action, suit or proceeding; or (c)&#8194;Independent legal counsel, in a written opinion, if: (1)&#8194;A majority vote of a quorum consisting of directors who were not
            parties to the action, suit or proceeding so orders; or (2)&#8194;A quorum consisting of directors who were not parties to the action, suit or proceeding cannot be obtained.&#8221;</div>
        </td>
      </tr>

  </table>
  <div>&#160;</div>
  <div> </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageBreak" style="page-break-after:always;">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="z8b39f1c2760a4aa49fa62812a1fd28da" class="DSPFListTable">

        <tr style="vertical-align: top;">
          <td style="vertical-align: top; width: 45pt;">
            <div style="text-align: left;"><font style="font-weight: bold; color: rgb(0, 0, 0);">Item 7.</font></div>
          </td>
          <td style="align: left; vertical-align: top; width: auto;">
            <div style="text-align: left;"><font style="font-weight: bold; color: rgb(0, 0, 0);">Exemption from Registration Claimed.</font></div>
          </td>
        </tr>

    </table>
  </div>
  <div>&#160;</div>
  <div style="text-align: justify; color: rgb(0, 0, 0);">Not applicable.</div>
  <div>&#160;</div>
  <div>
    <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="z8b2a4302c19c49afa1f7df47e5db6673" class="DSPFListTable">

        <tr style="vertical-align: top;">
          <td style="vertical-align: top; width: 45pt;">
            <div style="text-align: left;"><font style="font-weight: bold; color: rgb(0, 0, 0);">Item 8.</font></div>
          </td>
          <td style="align: left; vertical-align: top; width: auto;">
            <div style="text-align: left;"><font style="font-weight: bold; color: rgb(0, 0, 0);">Exhibits.</font></div>
          </td>
        </tr>

    </table>
  </div>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" id="z561381b1cf3e441fa30b40bd91122972" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

      <tr>
        <td style="width: 10%; vertical-align: middle; border-bottom: #000000 2px solid;">
          <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Exhibit Number</div>
        </td>
        <td style="width: 1.49%; vertical-align: middle;">&#160;</td>
        <td style="width: 88.51%; vertical-align: bottom; border-bottom: #000000 2px solid;">
          <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">Description</div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: #CCEEFF;">
          <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/1092662/000109266210000082/ex3_1.htm">3.1</a></div>
        </td>
        <td style="width: 1.49%; vertical-align: top; background-color: #CCEEFF;">&#160;</td>
        <td style="width: 88.51%; vertical-align: top; background-color: #CCEEFF;">
          <div style="text-align: justify; color: rgb(0, 0, 0);">Articles of Incorporation, as amended, of Chembio Diagnostics, Inc. (incorporated by reference to Exhibit 3.1 to the Registrant&#8217;s Quarterly Report on Form 10-Q filed with the SEC on July 29,
            2010)</div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/1092662/000114036118038547/ex3_2.htm">3.2</a></div>
        </td>
        <td style="width: 1.49%; vertical-align: top;">&#160;</td>
        <td style="width: 88.51%; vertical-align: top;">
          <div style="text-align: justify; color: rgb(0, 0, 0);">Amended and Restated Bylaws of Chembio Diagnostics, Inc. (incorporated by reference to Exhibit 3.2 to the Registrant&#8217;s Current Report on Form 8-K filed with the SEC on September 17, 2018)</div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: #CCEEFF;">
          <div style="text-align: center;"><a href="brhc10032843_ex5-1.htm">5.1</a></div>
        </td>
        <td style="width: 1.49%; vertical-align: top; background-color: #CCEEFF;">&#160;</td>
        <td style="width: 88.51%; vertical-align: top; background-color: #CCEEFF;">
          <div style="text-align: justify; color: rgb(0, 0, 0);">Opinion of Ballard Spahr LLP</div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="text-align: center;"><a href="brhc10032843_ex23-1.htm">23.1</a></div>
        </td>
        <td style="width: 1.49%; vertical-align: top;">&#160;</td>
        <td style="width: 88.51%; vertical-align: top;">
          <div style="text-align: justify; color: rgb(0, 0, 0);">Consent of Ernst &amp; Young LLP</div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: #CCEEFF;">
          <div style="text-align: center;"><a href="brhc10032843_ex23-2.htm">23.2</a></div>
        </td>
        <td style="width: 1.49%; vertical-align: top; background-color: #CCEEFF;">&#160;</td>
        <td style="width: 88.51%; vertical-align: top; background-color: #CCEEFF;">
          <div style="text-align: justify; color: rgb(0, 0, 0);">Consent of BDO USA, LLP</div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="text-align: center;"><a href="brhc10032843_ex5-1.htm">23.3</a></div>
        </td>
        <td style="width: 1.49%; vertical-align: top;">&#160;</td>
        <td style="width: 88.51%; vertical-align: top;">
          <div style="text-align: justify; color: rgb(0, 0, 0);">Consent of Ballard Spahr LLP (included in Exhibit 5.1)</div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: #CCEEFF;">
          <div style="text-align: center;"><a href="#SIGNATURE">24.1</a></div>
        </td>
        <td style="width: 1.49%; vertical-align: top; background-color: #CCEEFF;">&#160;</td>
        <td style="width: 88.51%; vertical-align: top; background-color: #CCEEFF;">
          <div style="text-align: justify; color: rgb(0, 0, 0);">Power of Attorney (included on the signature page)</div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="text-align: center;"><a href="https://www.sec.gov/Archives/edgar/data/0001092662/000114036122000855/brhc10032547_ex10-1.htm">99.1</a></div>
        </td>
        <td style="width: 1.49%; vertical-align: top;">&#160;</td>
        <td style="width: 88.51%; vertical-align: top;">
          <div style="text-align: justify; color: rgb(0, 0, 0);">Employment Agreement, dated as of December 30, 2021 and effective as of January 5, 2022, between Chembio Diagnostics, Inc. and Lawrence J. Steenvoorden (incorporated by reference to Exhibit
            10.1 to the Registrant&#8217;s Current Report on Form 8-K filed with the SEC on January 6, 2022)</div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top; background-color: #CCEEFF;">
          <div style="text-align: center;"><a href="brhc10032843_ex99-2.htm">99.2</a></div>
        </td>
        <td style="width: 1.49%; vertical-align: top; background-color: #CCEEFF;">&#160;</td>
        <td style="width: 88.51%; vertical-align: top; background-color: #CCEEFF;">
          <div style="text-align: justify; color: rgb(0, 0, 0);">Form of Non-Qualified Stock Option Agreement for Inducement Grant</div>
        </td>
      </tr>
      <tr>
        <td style="width: 10%; vertical-align: top;">
          <div style="text-align: center;"><a href="brhc10032843_ex99-3.htm">99.3</a></div>
        </td>
        <td style="width: 1.49%; vertical-align: top;">&#160;</td>
        <td style="width: 88.51%; vertical-align: top;">
          <div style="text-align: justify; color: rgb(0, 0, 0);">Form of Restricted Stock Unit Agreement for Inducement Grant</div>
        </td>
      </tr>

  </table>
  <div><br>
  </div>
  <div>
    <table cellspacing="0" cellpadding="0" style="width: 100%; font-family: 'Times New Roman'; font-size: 10pt;" id="zc8c74b403b274260b7b76cf9d5c7e40c" class="DSPFListTable">

        <tr style="vertical-align: top;">
          <td style="vertical-align: top; width: 45pt;">
            <div style="text-align: left;"><font style="font-weight: bold; color: rgb(0, 0, 0);">Item 9.</font></div>
          </td>
          <td style="align: left; vertical-align: top; width: auto;">
            <div style="text-align: left;"><font style="font-weight: bold; color: rgb(0, 0, 0);">Undertakings</font></div>
          </td>
        </tr>

    </table>
  </div>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" id="z8ade6963034049fe8f895bcdd5d7d5d1" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

      <tr>
        <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">1.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div style="color: rgb(0, 0, 0);">The Company hereby undertakes:</div>
        </td>
      </tr>

  </table>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" id="z9efad21c1c2e48c1946a2d7c799fb80a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

      <tr>
        <td style="width: 18pt;"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(a)</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div style="color: rgb(0, 0, 0);">to file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:</div>
        </td>
      </tr>

  </table>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" id="z428fe077a5fb4c90812f1979f94e47db" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

      <tr>
        <td style="width: 36pt;"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(i)</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div style="color: rgb(0, 0, 0);">to include any prospectus required by Section 10(a)(3) of the Securities Act;</div>
        </td>
      </tr>

  </table>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" id="zc2007dc0a965402293342375034a25bd" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

      <tr>
        <td style="width: 36pt;"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(ii)</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div style="color: rgb(0, 0, 0);">to reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate,
            represent a fundamental change in the information set forth in the registration statement; and</div>
        </td>
      </tr>

  </table>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" id="zca5fae536fda4fac8e0d75d74bf72852" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

      <tr>
        <td style="width: 36pt;"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(iii)</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div style="color: rgb(0, 0, 0);">to include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;</div>
        </td>
      </tr>

  </table>
  <div>&#160;</div>
  <div style="text-align: justify; margin-left: 36pt; color: rgb(0, 0, 0);"><font style="font-style: italic;">provided, however, </font>that paragraphs (a)(i) and (a)(ii) do not apply if the registration statement is on Form S&#8209;8 and the information
    required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Securities and Exchange Commission by the Company pursuant to Section 13 or 15(d) of the Exchange Act that are incorporated
    by reference in the registration statement;</div>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" id="ze9307c9bb80b485fbab038c7e291fae0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

      <tr>
        <td style="width: 18pt;"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(b)</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div style="color: rgb(0, 0, 0);">that, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered herein, and
            the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof; and</div>
        </td>
      </tr>

  </table>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" id="z6a96ae1c5a094b0994741d76711a6d94" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

      <tr>
        <td style="width: 18pt;"><br>
        </td>
        <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">(c)</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div style="color: rgb(0, 0, 0);">to remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.</div>
        </td>
      </tr>

  </table>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" id="z1476b969a73b4c81b04af50b954f1454" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

      <tr>
        <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">2.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div style="color: rgb(0, 0, 0);">The undersigned Company hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Company&#8217;s annual report pursuant to Section 13(a) or 15(d) of the Exchange
            Act (and, where applicable, each filing of an employee benefit plan&#8217;s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration
            statement relating to the securities offered herein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.</div>
        </td>
      </tr>

  </table>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" id="ze9b78cc1f6f1441cb406b1a786d48148" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

      <tr>
        <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0);">3.</td>
        <td style="width: auto; vertical-align: top; text-align: justify;">
          <div style="color: rgb(0, 0, 0);">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Company pursuant to the foregoing provisions, or otherwise, the
            Company has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for
            indemnification against such liabilities (other than the payment by the Company of expenses incurred or paid by a director, officer or controlling person of the Company in the successful defense of any action, suit or proceeding) is asserted by
            such director, officer or controlling person in connection with the securities being registered, the Company will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate
            jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.</div>
        </td>
      </tr>

  </table>
  <div> <br>
  </div>
  <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div id="DSPFPageBreak" style="page-break-after:always;">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">SIGNATURE<a name="SIGNATURE"><!--Anchor--></a></div>
  <div>&#160;</div>
  <div style="text-align: justify; color: rgb(0, 0, 0);">Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has
    duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Hauppauge, State of New York, as of January 14, 2022.</div>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" id="zf6a7928d35bc404e8f94d13f5544e637" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td style="width: 50%; vertical-align: top;">
          <div style="color: rgb(0, 0, 0); font-weight: bold;">CHEMBIO DIAGNOSTICS, INC.</div>
        </td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td style="width: 50%; vertical-align: top; border-bottom: #000000 2px solid;">
          <div style="color: rgb(0, 0, 0);">/s/ Richard L. Eberly</div>
        </td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td style="width: 50%; vertical-align: top;">
          <div style="color: rgb(0, 0, 0);">Richard L. Eberly</div>
        </td>
      </tr>
      <tr>
        <td style="width: 50%; vertical-align: top;">&#160;</td>
        <td style="width: 50%; vertical-align: top;">
          <div style="color: rgb(0, 0, 0);">Chief Executive Officer and President</div>
        </td>
      </tr>

  </table>
  <div> <br>
  </div>
  <div style="text-align: center; color: rgb(0, 0, 0); font-weight: bold;">POWER OF ATTORNEY AND SIGNATURES</div>
  <div>&#160;</div>
  <div style="text-align: justify; color: rgb(0, 0, 0);">KNOW ALL PERSONS BY THESE PRESENTS that each person whose signature appears below constitutes and appoints Richard L. Eberly and Lawrence J. Steenvoorden, and each or either of them, as his or her
    true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her, and in his or her name in any and all capacities, to sign any and all amendments (including post-effective amendments) to this
    registration statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and
    authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said
    attorneys-in-fact and agents, or either of them, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</div>
  <div>&#160;</div>
  <div style="text-align: justify; color: rgb(0, 0, 0);">Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed below by the following persons on behalf of the registrant in the capacities and on the dates
    indicated.</div>
  <div>&#160;</div>
  <table cellspacing="0" cellpadding="0" border="0" id="za5e684e607d643c787364f5ebdfa1f90" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

      <tr>
        <td style="width: 36%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="color: rgb(0, 0, 0); font-variant: small-caps; font-weight: bold;">Signature</div>
        </td>
        <td style="width: 1.92%; vertical-align: top;">&#160;</td>
        <td style="width: 42.92%; vertical-align: top; border-bottom: #000000 2px solid;">
          <div style="color: rgb(0, 0, 0); font-variant: small-caps; font-weight: bold;">Title</div>
        </td>
        <td style="width: 1.84%; vertical-align: top;">&#160;</td>
        <td style="width: 16.78%; vertical-align: top; border-bottom: #000000 2px solid;">
          <div style="color: rgb(0, 0, 0); font-variant: small-caps; font-weight: bold;">Date</div>
        </td>
      </tr>
      <tr>
        <td style="width: 36%; vertical-align: bottom;">&#160;</td>
        <td style="width: 1.92%; vertical-align: bottom;">&#160;</td>
        <td style="width: 42.92%; vertical-align: bottom;">&#160;</td>
        <td style="width: 1.84%; vertical-align: bottom;">&#160;</td>
        <td style="width: 16.78%; vertical-align: bottom;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 36%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="color: rgb(0, 0, 0);">/s/ Richard L. Eberly</div>
        </td>
        <td style="width: 1.92%; vertical-align: bottom;">&#160;</td>
        <td style="width: 42.92%; vertical-align: bottom;">
          <div style="color: rgb(0, 0, 0);">Chief Executive Officer, President and Director</div>
        </td>
        <td style="width: 1.84%; vertical-align: bottom;">&#160;</td>
        <td style="width: 16.78%; vertical-align: bottom;">January 14, 2022<br>
        </td>
      </tr>
      <tr>
        <td style="width: 36%; vertical-align: top;">
          <div style="color: rgb(0, 0, 0);">Richard L. Eberly</div>
        </td>
        <td style="width: 1.92%; vertical-align: top;">&#160;</td>
        <td style="width: 42.92%; vertical-align: bottom;">
          <div style="color: rgb(0, 0, 0); font-style: italic;">(Principal Executive Officer)</div>
        </td>
        <td style="width: 1.84%; vertical-align: top;">&#160;</td>
        <td style="width: 16.78%; vertical-align: bottom;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 36%; vertical-align: top;">&#160;</td>
        <td style="width: 1.92%; vertical-align: top;">&#160;</td>
        <td style="width: 42.92%; vertical-align: bottom;">&#160;</td>
        <td style="width: 1.84%; vertical-align: top;">&#160;</td>
        <td style="width: 16.78%; vertical-align: bottom;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 36%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="color: rgb(0, 0, 0);">/s/ Lawrence J. Steenvoorden<br>
          </div>
        </td>
        <td style="width: 1.92%; vertical-align: top;">&#160;</td>
        <td style="width: 42.92%; vertical-align: bottom;"> Executive Vice President and Chief Financial Officer<br>
        </td>
        <td style="width: 1.84%; vertical-align: top;">&#160;</td>
        <td style="width: 16.78%; vertical-align: bottom;">January 14, 2022<br>
        </td>
      </tr>
      <tr>
        <td style="width: 36%; vertical-align: top;"> Lawrence J.Steenvoorden </td>
        <td style="width: 1.92%; vertical-align: top;">&#160;</td>
        <td style="width: 42.92%; vertical-align: bottom;">
          <div style="color: rgb(0, 0, 0); font-style: italic;">(Principal Financial and Accounting Officer)</div>
        </td>
        <td style="width: 1.84%; vertical-align: top;">&#160;</td>
        <td style="width: 16.78%; vertical-align: bottom;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 36%; vertical-align: top;">&#160;</td>
        <td style="width: 1.92%; vertical-align: top;">&#160;</td>
        <td style="width: 42.92%; vertical-align: bottom;">&#160;</td>
        <td style="width: 1.84%; vertical-align: top;">&#160;</td>
        <td style="width: 16.78%; vertical-align: bottom;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 36%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="color: rgb(0, 0, 0);">/s/ David W.K. Acheson</div>
        </td>
        <td style="width: 1.92%; vertical-align: top;">&#160;</td>
        <td style="width: 42.92%; vertical-align: bottom;">&#160;</td>
        <td style="width: 1.84%; vertical-align: top;">&#160;</td>
        <td style="width: 16.78%; vertical-align: bottom;">&#160;January 14, 2022</td>
      </tr>
      <tr>
        <td style="width: 36%; vertical-align: top;">
          <div style="color: rgb(0, 0, 0);">David W.K. Acheson</div>
        </td>
        <td style="width: 1.92%; vertical-align: top;">&#160;</td>
        <td style="width: 42.92%; vertical-align: bottom;">
          <div style="color: rgb(0, 0, 0);">Director</div>
        </td>
        <td style="width: 1.84%; vertical-align: top;">&#160;</td>
        <td style="width: 16.78%; vertical-align: bottom;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 36%; vertical-align: top;">&#160;</td>
        <td style="width: 1.92%; vertical-align: top;">&#160;</td>
        <td style="width: 42.92%; vertical-align: bottom;">&#160;</td>
        <td style="width: 1.84%; vertical-align: top;">&#160;</td>
        <td style="width: 16.78%; vertical-align: bottom;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 36%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="color: rgb(0, 0, 0);">/s/ David W. Bespalko</div>
        </td>
        <td style="width: 1.92%; vertical-align: top;">&#160;</td>
        <td style="width: 42.92%; vertical-align: bottom;">&#160;</td>
        <td style="width: 1.84%; vertical-align: top;">&#160;</td>
        <td style="width: 16.78%; vertical-align: bottom;">January 14, 2022<br>
        </td>
      </tr>
      <tr>
        <td style="width: 36%; vertical-align: bottom;">
          <div style="color: rgb(0, 0, 0);">David W. Bespalko</div>
        </td>
        <td style="width: 1.92%; vertical-align: bottom;">&#160;</td>
        <td style="width: 42.92%; vertical-align: bottom;">
          <div style="color: rgb(0, 0, 0);">Director</div>
        </td>
        <td style="width: 1.84%; vertical-align: bottom;">&#160;</td>
        <td style="width: 16.78%; vertical-align: bottom;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 36%; vertical-align: bottom;">&#160;</td>
        <td style="width: 1.92%; vertical-align: bottom;">&#160;</td>
        <td style="width: 42.92%; vertical-align: bottom;">&#160;</td>
        <td style="width: 1.84%; vertical-align: bottom;">&#160;</td>
        <td style="width: 16.78%; vertical-align: bottom;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 36%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="color: rgb(0, 0, 0);">/s/ Katherine L. Davis</div>
        </td>
        <td style="width: 1.92%; vertical-align: bottom;">&#160;</td>
        <td style="width: 42.92%; vertical-align: bottom;">&#160;</td>
        <td style="width: 1.84%; vertical-align: bottom;">&#160;</td>
        <td style="width: 16.78%; vertical-align: bottom;">January 14, 2022<br>
        </td>
      </tr>
      <tr>
        <td style="width: 36%; vertical-align: bottom;">
          <div style="color: rgb(0, 0, 0);">Katherine L. Davis</div>
        </td>
        <td style="width: 1.92%; vertical-align: bottom;">&#160;</td>
        <td style="width: 42.92%; vertical-align: bottom;">
          <div style="color: rgb(0, 0, 0);">Director</div>
        </td>
        <td style="width: 1.84%; vertical-align: bottom;">&#160;</td>
        <td style="width: 16.78%; vertical-align: bottom;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 36%; vertical-align: bottom;">&#160;</td>
        <td style="width: 1.92%; vertical-align: bottom;">&#160;</td>
        <td style="width: 42.92%; vertical-align: bottom;">&#160;</td>
        <td style="width: 1.84%; vertical-align: bottom;">&#160;</td>
        <td style="width: 16.78%; vertical-align: bottom;">&#160;</td>
      </tr>
      <tr>
        <td style="width: 36%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
          <div style="color: rgb(0, 0, 0);">/s/ John G. Potthoff</div>
        </td>
        <td style="width: 1.92%; vertical-align: bottom;">&#160;</td>
        <td style="width: 42.92%; vertical-align: bottom;">&#160;</td>
        <td style="width: 1.84%; vertical-align: bottom;">&#160;</td>
        <td style="width: 16.78%; vertical-align: bottom;">January 14, 2022<br>
        </td>
      </tr>
      <tr>
        <td style="width: 36%; vertical-align: bottom;">
          <div style="color: rgb(0, 0, 0);">John G. Potthoff</div>
        </td>
        <td style="width: 1.92%; vertical-align: bottom;">&#160;</td>
        <td style="width: 42.92%; vertical-align: bottom;">
          <div style="color: rgb(0, 0, 0);">Director</div>
        </td>
        <td style="width: 1.84%; vertical-align: bottom;">&#160;</td>
        <td style="width: 16.78%; vertical-align: bottom;">&#160;</td>
      </tr>

  </table>
  <div><br>
  </div>
  <div><br>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
[{"type": "S-8", "sequence": "1", "filename": "brhc10032843_s8.htm", "description": "S-8", "secsgml_size_bytes": 64856}]
{"company-data": {"conformed-name": "CHEMBIO DIAGNOSTICS, INC.", "cik": "0001092662", "assigned-sic": "2834", "irs-number": "880425691", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-262199", "film-number": "22533000"}, "business-address": {"street1": "555 WIRELESS BLVD.", "city": "HAUPPAUGE", "state": "NY", "zip": "11788", "phone": "(631) 924-1135"}, "mail-address": {"street1": "555 WIRELESS BLVD.", "city": "HAUPPAUGE", "state": "NY", "zip": "11788"}, "former-company": [{"former-conformed-name": "Chembio Diagnostics Inc.", "date-changed": "20040607"}, {"former-conformed-name": "TRADING SOLUTIONS COM INC", "date-changed": "19990805"}]}
As filed with the Securities and Exchange Commission on January 14, 2022
Registration No. 333-
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER THE SECURITIES ACT OF 1933
CHEMBIO DIAGNOSTICS, INC.
(Exact name of registrant as specified in its charter)
Nevada
88-0425691
(State or other jurisdiction of
(I.R.S. Employer Identification No.
Incorporation or organization)
555 Wireless Blvd.
Hauppauge, New York
11788
(Address of principal executive offices)
(Zip code)
Employment Agreement dated as of December 30, 2021 with Lawrence J. Steenvoorden
(Full title of the plan)
Richard L. Eberly
Chief Executive Officer and President
Chembio Diagnostics, Inc.
555 Wireless Blvd., Hauppauge, New York 11788
(631) 924-1135
(Name, address, including zip code, and telephone number, including area code, of agent for service)
With a copy to:
Mark L. Johnson
Bella Zaslavsky
K&L Gates LLP
One Lincoln Street, Boston, Massachusetts 02111
(617) 261-3260
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the
    definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☐
Accelerated filer
☐
Non-accelerated filer
☐
Smaller reporting company
☒
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revise financial accounting standards
    provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
CALCULATION OF REGISTRATION FEE
Title of Securities to be Registered
Amount to be
registered(1)
Proposed maximum
offering price per
share(2)
Proposed maximum
aggregate offering
price(2)
Amount of
registration
fee
Common stock, $0.01 par value per share
460,714
$1.11
$511,392.54
$47.41
(1)
Consists of shares authorized for issuance under the registrant's Employment Agreement dated as of December 30, 2021 with Lawrence J. Steenvoorden. In accordance with Rule 416 under the Securities Act of 1933,
            this registration statement shall be deemed to cover any additional securities that may from time to time be offered or issued to prevent dilution resulting from stock splits, stock dividends or similar transactions.
(2)
Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and (h) under the Securities Act of 1933 and based upon the average of the high and low prices of the registrant's
            common stock as reported on the Nasdaq Capital Market on January 7, 2022.
This Registration Statement on Form S-8 is being filed by Chembio Diagnostics, Inc. (the "Company") for the purpose of registering 460,714 shares of the Company's common stock, $0.01 par value per
    share ("Common Stock"), authorized for issuance under the Employment Agreement dated as of December 30, 2021 between the Company and Lawrence J. Steenvoorden. Such Employment Agreement is referred to below as the "Plan."
PART I
INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
Item 1.
Plan Information.
The information required by Item 1 is included in documents sent or given by the Company to the participant in the Plan pursuant to Rule 428(b)(1) of the Securities Act of 1933 (the "Securities
    Act").
Item 2.
Registrant Information and Employee Plan Annual Information.
The written statement required by Item 2 is included in documents sent or given by the Company to participant in the Plan pursuant to Rule 428(b)(1) of the Securities Act.
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3.
Incorporation of Documents by Reference.
The following documents filed by the Company with the Securities and Exchange Commission are incorporated by reference in this registration statement:
(a)
the Company's latest annual report on
Form 10-K
filed pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (the "Exchange Act") that contains audited financial statements for the Company's latest fiscal year for which such statements have
              been filed;
(b)
all other reports filed pursuant to Section 13(a) or 15(d) of the Exchange Act since the end of the fiscal year covered by the annual report referred to in (a) above; and
(c)
the description of the Common Stock set forth in
Exhibit 4.2
to the Company's Annual Report on
Form 10-K
for the fiscal year ended December 31, 2020, filed with the SEC on March 11, 2021, together with any amendment or report
              filed with the SEC for the purpose of updating such description.
All reports and other documents subsequently filed by the Company pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act prior to the filing of a post-effective amendment that indicates
    that all securities offered have been sold, or that deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this registration statement and to be part of this registration statement from the respective dates
    of the filing of such reports and other documents.
Item 4.
Description of Securities.
Not applicable.
Item 5.
Interests of Named Experts and Counsel
Ballard Spahr LLP has opined as to the legality of the shares of Common Stock being offered by this registration statement.
Item 6.
Indemnification of Directors and Officers.
The Company's bylaws provide that it will indemnify any of its directors, officers, other employees or agents against expenses (including attorneys' fees), judgments, fines and amounts paid in
    settlement actually and reasonably incurred by such director, officer, other employee or agent in connection with any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative, relating to
    service for or at the request of the Company. The Company will not indemnify a director, officer, other employee or agent if in relation to matters such director, officer, other employee or agent is adjudged in the action, suit or proceeding to not
    have acted in good faith and in a manner reasonably believed to be in or not opposed to the best interests of the Company in the performance of the individual's duties.
The Company's bylaws also provide that it will advance expenses (including attorneys' fees) incurred by an officer or director defending an action, suit or proceeding, upon receipt of an undertaking
    by or on behalf of such officer or director to repay such amount if that officer of director is determined to not be entitled to indemnification. Such expenses incurred by other employees and agents may be paid in advance by the Company upon certain
    terms and conditions deemed appropriate by the board of directors of the Company.
The Company's articles of incorporation provide that no director will be personally liable to the Company or its stockholders for monetary damages for breach of fiduciary duty as a director, except
    that the director's liability will not be eliminated or limited: (A) for acts or omissions involving intentional misconduct, fraud or a knowing violation of the law; or (B) for the payment of any distribution in violation of Nevada law.
Nevada law permits a Nevada corporation, such as the Company, to indemnify its directors and officers in certain circumstances. Specifically, Section 78.7502 of the Nevada Revised Statutes provides
    as follows:
"(1)
A corporation may indemnify pursuant to this subsection any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil,
            criminal, administrative or investigative, except an action by or in the right of the corporation, by reason of the fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of
            the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses, including attorneys' fees, judgments, fines and amounts paid in settlement actually and
            reasonably incurred by the person in connection with the action, suit or proceeding if the person: (a) is not liable pursuant to Nevada Revised Statutes 78.138; or (b) acted in good faith and in a manner which he or she reasonably believed to
            be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe the conduct was unlawful. The termination of any action, suit or proceeding by judgment,
            order, settlement, conviction or upon a plea of nolo contendere or its equivalent, does not, of itself, create a presumption that the person is liable pursuant to Nevada Revised Statutes 78.138 or did not act in good faith and in a manner which
            he or she reasonably believed to be in or not opposed to the best interests of the corporation, or that, with respect to any criminal action or proceeding, he or she had reasonable cause to believe that the conduct was unlawful.
"(2)
A corporation may indemnify pursuant to this subsection any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the
            corporation to procure a judgment in its favor by reason of the fact that the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or
            agent of another corporation, partnership, joint venture, trust or other enterprise against expenses, including amounts paid in settlement and attorneys' fees actually and reasonably incurred by the person in connection with the defense or
            settlement of the action or suit if the person: (a) is not liable pursuant to Nevada Revised Statutes 78.138; or (b) acted in good faith and in a manner which he or she reasonably believed to be in or not opposed to the best interests of the
            corporation. Indemnification pursuant to this section may not be made for any claim, issue or matter as to which such a person has been adjudged by a court of competent jurisdiction, after exhaustion of any appeals taken therefrom, to be liable
            to the corporation or for amounts paid in settlement to the corporation, unless and only to the extent that the court in which the action or suit was brought or other court of competent jurisdiction determines upon application that in view of
            all the circumstances of the case, the person is fairly and reasonably entitled to indemnity for such expenses as the court deems proper.
"(3)
Any discretionary indemnification pursuant to this section, unless ordered by a court or advanced pursuant to subsection 2 of Nevada Revised Statutes 78.751, may be made by the corporation only as authorized in
            each specific case upon a determination that the indemnification of a director, officer, employee or agent of a corporation is proper under the circumstances. The determination must be made by: (a) The stockholders; (b) The board of directors,
            by majority vote of a quorum consisting of directors who were not parties to the action, suit or proceeding; or (c) Independent legal counsel, in a written opinion, if: (1) A majority vote of a quorum consisting of directors who were not
            parties to the action, suit or proceeding so orders; or (2) A quorum consisting of directors who were not parties to the action, suit or proceeding cannot be obtained."
Item 7.
Exemption from Registration Claimed.
Not applicable.
Item 8.
Exhibits.
Exhibit Number
Description
3.1
Articles of Incorporation, as amended, of Chembio Diagnostics, Inc. (incorporated by reference to Exhibit 3.1 to the Registrant's Quarterly Report on Form 10-Q filed with the SEC on July 29,
            2010)
3.2
Amended and Restated Bylaws of Chembio Diagnostics, Inc. (incorporated by reference to Exhibit 3.2 to the Registrant's Current Report on Form 8-K filed with the SEC on September 17, 2018)
5.1
Opinion of Ballard Spahr LLP
23.1
Consent of Ernst & Young LLP
23.2
Consent of BDO USA, LLP
23.3
Consent of Ballard Spahr LLP (included in Exhibit 5.1)
24.1
Power of Attorney (included on the signature page)
99.1
Employment Agreement, dated as of December 30, 2021 and effective as of January 5, 2022, between Chembio Diagnostics, Inc. and Lawrence J. Steenvoorden (incorporated by reference to Exhibit
            10.1 to the Registrant's Current Report on Form 8-K filed with the SEC on January 6, 2022)
99.2
Form of Non-Qualified Stock Option Agreement for Inducement Grant
99.3
Form of Restricted Stock Unit Agreement for Inducement Grant
Item 9.
Undertakings
1.
The Company hereby undertakes:
(a)
to file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:
(i)
to include any prospectus required by Section 10(a)(3) of the Securities Act;
(ii)
to reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate,
            represent a fundamental change in the information set forth in the registration statement; and
(iii)
to include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;
provided, however,
that paragraphs (a)(i) and (a)(ii) do not apply if the registration statement is on Form S‑8 and the information
    required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Securities and Exchange Commission by the Company pursuant to Section 13 or 15(d) of the Exchange Act that are incorporated
    by reference in the registration statement;
(b)
that, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered herein, and
            the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof; and
(c)
to remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
2.
The undersigned Company hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Company's annual report pursuant to Section 13(a) or 15(d) of the Exchange
            Act (and, where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration
            statement relating to the securities offered herein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
3.
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Company pursuant to the foregoing provisions, or otherwise, the
            Company has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for
            indemnification against such liabilities (other than the payment by the Company of expenses incurred or paid by a director, officer or controlling person of the Company in the successful defense of any action, suit or proceeding) is asserted by
            such director, officer or controlling person in connection with the securities being registered, the Company will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate
            jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
SIGNATURE
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has
    duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Hauppauge, State of New York, as of January 14, 2022.
CHEMBIO DIAGNOSTICS, INC.
/s/ Richard L. Eberly
Richard L. Eberly
Chief Executive Officer and President
POWER OF ATTORNEY AND SIGNATURES
KNOW ALL PERSONS BY THESE PRESENTS that each person whose signature appears below constitutes and appoints Richard L. Eberly and Lawrence J. Steenvoorden, and each or either of them, as his or her
    true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her, and in his or her name in any and all capacities, to sign any and all amendments (including post-effective amendments) to this
    registration statement, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and
    authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said
    attorneys-in-fact and agents, or either of them, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed below by the following persons on behalf of the registrant in the capacities and on the dates
    indicated.
Signature
Title
Date
/s/ Richard L. Eberly
Chief Executive Officer, President and Director
January 14, 2022
Richard L. Eberly
(Principal Executive Officer)
/s/ Lawrence J. Steenvoorden
Executive Vice President and Chief Financial Officer
January 14, 2022
Lawrence J.Steenvoorden
(Principal Financial and Accounting Officer)
/s/ David W.K. Acheson
January 14, 2022
David W.K. Acheson
Director
/s/ David W. Bespalko
January 14, 2022
David W. Bespalko
Director
/s/ Katherine L. Davis
January 14, 2022
Katherine L. Davis
Director
/s/ John G. Potthoff
January 14, 2022
John G. Potthoff
Director